Inovio Pharmaceuticals Investor Relations Material

Inovio Pharmaceuticals Inc. (INO) is a publicly traded biotechnology company headquartered in Plymouth Meeting, Pennsylvania. Inovio is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of DNA medicines to treat and prevent children and adults from infectious diseases as well as cancers. The Company uses its proprietary electroporation delivery technology to create enhanced cellular uptake of therapeutic DNA payload into target cells across multiple routes of administration.